Manufacturers Life Insurance Company, The Voyager Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 93,307 shares of VYGR stock, worth $370,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,307

Previous 93,895 0.63%

Holding current value

$370,428

Previous $549,000 3.64%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$5.27 - $8.07 $3,098 - $4,745	-588 Reduced 0.63%	93,307 $529,000
Q3 2024 Nov 13, 2024	SELL	$5.77 - $9.27 $2,902 - $4,662	-503 Reduced 0.53%	93,895 $549,000
Q2 2024 Aug 14, 2024	BUY	$7.42 - $10.54 $39,808 - $56,547	5,365 Added 6.03%	94,398 $746,000
Q1 2024 May 14, 2024	BUY	$7.15 - $10.84 $76,912 - $116,605	10,757 Added 13.74%	89,033 $828,000
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $8,806 - $17,753	1,269 Added 1.65%	78,276 $896,000
Q4 2022 Aug 11, 2023	SELL	$4.94 - $6.61 $2,119 - $2,835	-429 Reduced 0.55%	77,007 $469,000
Q4 2022 Feb 13, 2023	SELL	$4.94 - $6.61 $2,119 - $2,835	-429 Reduced 0.55%	77,007 $469,000
Q2 2022 Aug 11, 2023	BUY	$4.82 - $10.09 $2,067 - $4,328	429 Added 0.56%	77,436 $457,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $373,241 - $781,329	77,436 New	77,436 $460,000
Q1 2021 May 03, 2021	SELL	$4.61 - $9.04 $80,739 - $158,326	-17,514 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$7.15 - $12.28 $9,974 - $17,130	1,395 Added 8.65%	17,514 $125,000
Q2 2020 Aug 10, 2020	SELL	$8.05 - $14.21 $402 - $710	-50 Reduced 0.31%	16,119 $197,000
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $6,868 - $14,806	1,010 Added 6.66%	16,169 $148,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $3,743 - $4,920	-292 Reduced 1.89%	15,159 $211,000
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $296,350 - $430,773	15,451 New	15,451 $421,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $286,164 - $363,601	-16,725 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $56,447 - $80,562	3,368 Added 25.22%	16,725 $327,000
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $11,473 - $22,230	-710 Reduced 5.05%	13,357 $251,000
Q4 2017 Feb 08, 2018	BUY	$12.26 - $25.88 $13,093 - $27,639	1,068 Added 8.22%	14,067 $233,000
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $108,801 - $267,649	12,999	12,999 $268,000

Others Institutions Holding VYGR

# of Institutions

135

Shares Held

34.4M

Call Options Held

Put Options Held

60.4K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $153M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Voyager Therapeutics, Inc. Transaction History